NovaBridge Biosciences Capital Expenditures Incurred but Not yet Paid
NovaBridge Biosciences (NBP) reported Capital Expenditures Incurred but Not yet Paid of CNY 0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2024-04-30
| Period end | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|
| 2023-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |
| 2022-12-31 | 4.39M CNY 20-F · filed 2024-04-30 | |
| 2022-06-30 | 14.60M CNY 6-K · filed 2022-11-10 | |
| 2021-12-31 | 24.43M CNY 20-F · filed 2023-05-01 |